One platform for all researcher needs
AI-powered academic writing assistant
Your #1 AI companion for literature search
AI tool for graphics, illustrations, and artwork
Unlock unlimited use of all AI tools with the Editage Plus membership.
Explore Editage Plus
Audio Papers
Ask R Discovery
Translation
Auto-sync
Collaboration
Open Access
PDF Availablehttps://doi.org/10.1136/annrheumdis-2022-eular.3263
Copy DOI
Export
Save
Share
Cite Journal: Annals of the Rheumatic Diseases |  Publication Date: May 23, 2022 |
Affiliation: Hospital de Basurto, Hospital General Universitario Gregorio Marañón, Hospital Universitario Puerta de Hierro Majadahonda, Marqués de Valdecilla University Hospital, Hospital de Galdakao, Donostia Unibertsitate Ospitalea, Instituto de Investigación Biomédica de A Coruña, Complexo Hospitalario Universitario A Coruña, Research Institute Hospital 12 de Octubre, University of Alicante, University Hospital Complex Of Vigo
BackgroundUpadacitinib (UPA) is an inhibitor of JAK kinases recently approved by EMA for the treatment of psoriatic arthritis (PsA) in Europe (January 2021) 1. UPA has shown efficacy in refractory...
Free) Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
